Unlike the US, Canada and Australia, the UK has limited access to free boosters – but the cost of doing so could be huge
Trust me, no one, even in public health or medicine, wants to talk or think about Covid-19. The trauma of those pandemic years is burnt into our minds. But, whether we want to deal with it or not, Covid-19 is still affecting all of us, and circulating at fairly high levels in Britain this month. While community surveys are no longer conducted by the Office for National Statistics to estimate overall cases, hospital data from England indicates that the weekly hospital admission rate for Covid-19 is at 4.64 for every 100,000 people, with the north-east region at 8.91.
These figures just cover people who are admitted to hospital and don’t reflect those suffering at home or attending GP clinics. While we were mainly fixated on death rates during the pandemic, the longer legacy concerns people who had and cleared the infection, but are still suffering – what is usually referred to as long Covid.
Prof Devi Sridhar is chair of global public health at the University of Edinburgh
About Author
More Stories
Shrinking waistlines and growing profits: the weight-loss drug boom
‘Wild west’: experts concerned by illegal promotion of weight-loss jabs in UK
Esports are booming in Africa – but can its infrastructure keep pace?